Expression of normal and truncated forms of human endoglin.
about
Effect of antihypertensive therapy with alpha methyldopa on levels of angiogenic factors in pregnancies with hypertensive disordersStructure of betaglycan zona pellucida (ZP)-C domain provides insights into ZP-mediated protein polymerization and TGF- bindingRelationships between TGFbeta proteins and oxygen concentrations inside the first trimester human gestational sacEndoglin in liver fibrogenesis: Bridging basic science and clinical practiceInvestigation of endoglin wild-type and missense mutant protein heterodimerisation using fluorescence microscopy based IF, BiFC and FRET analyses.Structural and functional insights into endoglin ligand recognition and binding.From developmental disorder to heritable cancer: it's all in the BMP/TGF-beta family.Response to Plasmapheresis Measured by Angiogenic Factors in a Woman with Antiphospholipid Syndrome in Pregnancy.Generation of a floxed allele of the mouse Endoglin genePlacental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies.Hereditary hemorrhagic telangiectasia, a vascular dysplasia affecting the TGF-beta signaling pathwayDiagnostic and prognostic significance of serum soluble endoglin levels in preeclampsia and eclampsia.Use of ribosome-inactivating proteins from Sambucus for the construction of immunotoxins and conjugates for cancer therapy.In vitro and in vivo effects of an anti-mouse endoglin (CD105)-immunotoxin on the early stages of mouse B16MEL4A5 melanoma tumours.Anti-Human Endoglin (hCD105) Immunotoxin-Containing Recombinant Single Chain Ribosome-Inactivating Protein Musarmin 1.
P2860
Q21144276-9E4ECBA8-E961-4EEC-8634-5CA8E54C2434Q27667272-2EEA0CC5-768C-48F5-AF63-A89CF717B218Q33340308-D537B110-3560-4FC5-9187-498A25C63859Q33728841-1189C152-9785-4DF8-A613-D98DD1608333Q33981941-D76559FA-DBBB-4A30-8E8C-8BD22EAD38B1Q34162465-2331AFB7-CE85-4F49-AEB0-D8ACA14F5E6AQ35550184-3711E833-93DA-4C3F-AFCA-C6E7E290FD6BQ36043513-B48EC0E9-6CC9-4379-BBAD-5BF38D5E5C17Q36143403-0DCAA371-FC10-4F90-A5E3-3E30840C0C92Q36360771-57EBDAB1-E399-4D90-82D5-EF25231707D8Q36440899-ECE2766C-1CBE-4F5B-8EBB-AB31DC9F75B0Q37157819-7CD50FC7-7308-499F-88AF-D9CE7E9D2E78Q37954333-551D88F4-E005-46ED-920A-8F489846BCA5Q39257411-37AC2D2D-1563-4C0C-9514-FF9AE446B12CQ42253064-C5B4B11D-C939-40F7-8D0E-E4B4EB15B318
P2860
Expression of normal and truncated forms of human endoglin.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Expression of normal and truncated forms of human endoglin.
@en
type
label
Expression of normal and truncated forms of human endoglin.
@en
prefLabel
Expression of normal and truncated forms of human endoglin.
@en
P2093
P2860
P1433
P1476
Expression of normal and truncated forms of human endoglin.
@en
P2093
A Letamendía
J P López-Bote
P2860
P304
P356
10.1042/0264-6021:3390579
P407
P478
339 ( Pt 3)
P577
1999-05-01T00:00:00Z